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A retrospective study comparing the diagnostic
yield of atrial fibrillation in TIA patients using
external loop monitors and those using wireless
TeleECG bluetooth recorders
Wadea Tarhuni, Maher M. El-Masri
Background: AF is associated with approximately
10% of all ischemic strokes and with increased mortality.
Puposes: To compare the diagnostic yield of AF
between TIA patients who received cardiac monitoring
with external loop monitor and patients who received
cardiac monitoring with Wireless TeleECG Bluetooth
Recording devices.
Methods: A retrospective chart review was con-
ducted on 1012 TIA patients from January 2006 to Decem-
ber 2010. Adjusted stepwise logistic regression analysis
was performed to compare the diagnosis of AF between
the two devices while accounting for covariates.
Results: Patients who were monitored with Wireless
TeleECG Bluetooth Recording were over 9.0 times more
likely to be diagnosed with AF than patients monitored
with external loop monitor (OR = 9.15; 95%CI = 6.18–
13.56). Other independent predictors of AF were age
(OR = 1.052; 95%CI = 1.03–1.07), MBI (OR = 1.037;
95%CI = 1.01–1.07), and history of heart disease (OR
= 1.77; 95%CI = 1.17–2.69). Interestingly, neither diabetes
nor hypertension was significant predictors of AF in our
sample.
Conclusion: Wireless TeleECG Bluetooth Recording
are far more superior than external loop monitors with
regard to diagnosis of AF. Thus, the use of Wireless Tele-
Table 1
Clinical characteristic of patients in study. PCI: percutaneous coronary intervention CSA: chronic stable angina UA: unstable angina
+ve: positive.
All patients Patients with CSA Patients with UA
Age (mean ± SD) 53.7 ± 8.85 54 ± 8.93 53 ± 8.89
Male sex 36(87.8%) 23(82.1%) 13(100%)
Hypertension 13(31.7%) 8(28.6%) 5(38.5%)
Dyslipidemia 21(51.2%) 13(46.7%) 8(61.5%)
+ve family history 17(41.7%) 8(28.6%) 9(69.2%)
Smoker 3(7.3%) 3(10.7%) 0
Ex-smoker 25(61%) 14(50%) 11(84.6%)
Overweight 9(22%) 5(17.9%) 4(30.8%)
obese 18(43.9%) 14(50%) 4(30.8%)
Beta blocker 30(73.2%) 19(67.7%) 11(84.6%)
Statin 19(46.3%) 12(42.9%) 7(53.8%)
Table 2
Difference between pre procedure, 24 h post procedural hs_CRP in patients underwent PCI. PCI: percutaneous coronary intervention
CSA: chronic stable angina UA: unstable angina.
Hs-CRP lg/ml
Mean ± SD P-value
Patients underwent PCI Preprocedure 2.83 ± 2.21 0.007
24 h post procedure 7.43 ± 10.6
Patients with CSA Preprocedure 2.22 ± 2.21 0.008
24 h post procedure 6.48 ± 10.6
Patients with UA Preprocedure 4.253 ± 3.297 0.225
24 h post procedure 9.476 ± 14.632
Table 3
Incidence of procedural complication. CSA: chronic stable angina UA: unstable angina.
All patients Patients with CSA Patients with UA
Side branch occlusion 1(2.4%) 0 1(7.7%)
Thrombus formation 0 0 0
Coronary dissection 2(4.9%) 1(3.6%) 1(7.7%)
Embolization 0 0 0
Chest pain 3(7.3%) 2(7.1%) 1(7.7%)
Plaque shift 3(7.3%) 1(3.1%) 2(15.4%)
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ECG Bluetooth Recording devices could result in timely
treatment of AF, which could subsequently reduce the
risk of stroke. Further research within the context of clin-
ical trials is however needed.
http://dx.doi:10.1016/j.jsha.2012.06.261
Intraoperative loading dose of amiodarone for
prophylaxis against atrial fibrillation after valvular
heart surgery
Yasser Mohamed Amr, Elsayed M. Elmistekawy,
Abd-Almohsen M. Hammad
Objective: Benefit of amiodarone in restoring sinus
rhythm (SR) after cardiac surgery was concluded in pre-
vious studies that used different protocols for giving ami-
odarone. The purpose of this study was to assess the use
of single parenteral intraoperative loading dose of amio-
darone without maintenance as prophylaxis against atrial
fibrillation (AF) after valvular heart surgery.
Materials and methods: This was a prospective,
randomized, double-blind controlled study on 94
patients listed for valvular heart surgery. The patients
received either amiodarone, 3 mg/kg diluted in 100 ml
of normal saline and started prior to making skin incision
and administrated through venous line over a period of
30 min, or the same volume of normal saline infused in
a similar fashion. The incidence of AF during the first 5
days after surgery was the main outcome measured.
Results: There was significant difference in favor of
the amiodarone group regarding restoration of sinus
rhythm after aortic cross-clamp removal, number of
patients requiring cardioversion, incidence of AF and
the time elapsed before incidence of it postoperatively
(P values = 0.02, 0.04, 0.02, 0.02, respectively). There was
no difference in hospital mortality, major postoperative
morbidity, intensive care unit (ICU) stay or hospital stay.
Conclusions: Amiodarone prophylaxis in a single
intraoperative dose was significantly effective in preven-
tion of new-onset postoperative AF after valvular heart
surgery. This amiodarone dose is well tolerated and not
associated with postoperative complications.
http://dx.doi:10.1016/j.jsha.2012.06.262
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